Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance High-grade neuroendocrine carcinoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback